SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950116-05-000901
Filing Date
2005-03-04
Accepted
2005-03-04 16:08:30
Documents
1
Period of Report
2005-04-05

Document Format Files

Seq Description Document Type Size
1 PRE14A.TXT pre14a.txt PRE 14A 129733
  Complete submission text file 0000950116-05-000901.txt   131291
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-25169 | Film No.: 05661437
SIC: 2834 Pharmaceutical Preparations